BD to sell surgical devices business, 3 manufacturing facilities

Becton Dickinson plans to sell its surgical devices business and three manufacturing plants as part of a divestment planned for the end of 2023. 

Advertisement

Steris, an Ireland-based medical devices company, will buy Becton Dickinson’s surgical products business for $540 million, which includes manufacturing sites in St. Louis, Cleveland and Tuttlingen, Germany, according to a June 20 news release.

“Divesting the platform advances [… the company’s] 2025 strategy and is an important step in simplifying BD’s product portfolio and manufacturing network,” the release said.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.